← Leaderboards
Jeffrey N Bruce
Columbia University Health Sciences
$6,985,161
Attributed
$9,434,579
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $880.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,434,579 · 6
By mechanism
R01$8,897,592 · 3
M01$536,987 · 3
Top collaborators
- Peter D Canoll8 shared
- Peter Alan Sims8 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Jean Gautier$20,960,007
- Markus D Siegelin$6,883,771
- Peter D Canoll$11,470,200
- Anna Lasorella$11,657,863
- Peter Alan Sims$16,056,648
Others in their field
Top investigators on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Larry Arthur$195,389,208
- Norman Wolmark · Nsabp Foundation, Inc.$177,775,854
- Lawrence Corey · Fred Hutchinson Cancer Center$130,508,383
- Richard K. Wilson · Washington University$128,382,063
Research focus
Operative Surgical ProceduresAnimal ModelTumorResponseExcisionRecurrenceSamplingBrainGlioblastomaMagnetic Resonance ImagingTopotecanBrain NeoplasmsDrug Delivery SystemsGliomaChemotherapyInnovationBrain TissueMethodologyBiopsyMalignant GliomaImplantConvectionNeoplastic CellClinical Trials
Grant awards (26)
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence$648,602
R01 · FY2025 · NS · contact PI
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence$630,987
R01 · FY2024 · NS · contact PI
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence$652,348
R01 · FY2023 · NS · contact PI
Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence$348,948
R01 · FY2021 · NS
Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence$348,514
R01 · FY2020 · NS
Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence$348,234
R01 · FY2019 · NS
Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence$348,236
R01 · FY2018 · NS
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA$532,270
R01 · FY2017 · CA · contact PI
Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence$348,258
R01 · FY2017 · NS
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA$536,623
R01 · FY2016 · CA · contact PI
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA$541,974
R01 · FY2015 · CA · contact PI
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA$576,100
R01 · FY2014 · CA · contact PI
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA$88,962
R01 · FY2013 · CA · contact PI
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA$624,087
R01 · FY2012 · CA · contact PI
TOPOTECAN BY INTRACEREBRAL CLYSIS FOR BRAIN TUMORS$469,759
R01 · FY2006 · CA · contact PI
TOPOTECAN BY INTRACEREBRAL CLYSIS FOR BRAIN TUMORS$472,488
R01 · FY2005 · CA
TOPOTECAN BY INTRACEREBRAL CLYSIS /TREATMENT OF PRIMARY MALIGNANT BRAINTUMOR$29,999
M01 · FY2005 · RR
TOPOTECAN BY INTRACEREBRAL CLYSIS FOR BRAIN TUMORS$464,165
R01 · FY2004 · CA
TOPOTECAN BY INTRACEREBRAL CLYSIS FOR BRAIN TUMORS$455,535
R01 · FY2003 · CA
TOPOTECAN BY INTRACEREBRAL CLYSIS FOR BRAIN TUMORS$461,502
R01 · FY2002 · CA
RECOMBINANT CHIMERIC PROTEIN FOR RECURRENT ASTROCYTOMA$192,910
M01 · FY2002 · RR
RECOMBINANT CHIMERIC PROTEIN FOR RECURRENT ASTROCYTOMA$192,910
M01 · FY2001 · RR
RECOMBINANT CHIMERIC PROTEIN FOR RECURRENT ASTROCYTOMA$0
M01 · FY2001 · RR
INTRATUMORAL/INTERSTITIAL THERAPY WITH HN-6600 IN REFRACOTRY GLIOBLASTOMA$121,168
M01 · FY2000 · RR
RECOMBINANT CHIMERIC PROTEIN FOR RECURRENT ASTROCYTOMA$0
M01 · FY2000 · RR
RECOMBINANT CHIMERIC PROTEIN FOR RECURRENT ASTROCYTOMA$0
M01 · FY2000 · RR